Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity
Description
This article aims to propose practical solutions that coordinate the conflicting interests between the global community and the pharmaceutical industry on the intellectual property (IP) waiver for COVID-19 vaccines and facilitate a more equitable